» BioStock Investor Pitch: Dicot
» Lipum's clinical development journey continues in 2023
» Spermosens about the emission and development plan
» Iconovo begins 2023 with negotiations for ICOpre
» BioStock Investor Pitch: Spermosis
Read BioStock's newsletter for v.2 here.
BioStock Investor Pitch: If Dicots vd Elin Trampe present the company here or in the banner below.
Morning news
Pharmacologist reports WasteLog-order in the USA of approximately SEK 5 million. Read more.
Annex appoints Dr. Alain Thibault to Therapeutic Area Head Oncology. Read more.
Oncopeptides CFO Holger Lember takes office today. Read more.
RhoVac has completed the acquisition of Chosa and a new board and CEO have taken office. Read more.
Leading experts in pulmonary pharmacology and pulmonary medicine have been engaged as advisors to Arcede Pharma. Read more.
Scandinavian ChemoTech presenting at Redeye Fight Cancer Day. Read more.
Ortivus acquires shares in the company H&E Solutions. Read more.
David Dahlgren joins as a consultant in clinical pharmacology and DMPK at SDS Life Science. Read more.
Changes in equity:
Communiqués:
Report presentations:
News since Tuesday lunch
WntResearch has announced the outcome of the rights issue and information about warrants TO 5. Read more.
Idogen has announced the outcome of the rights issue. Read more.
SUFFER has published a prospectus in connection with an upcoming rights issue. Read more.
Amniotic has canceled the planned extraordinary general meeting and presents a new schedule for the planned rights issue. Read more.
BioInvent has been selected for The Leukemia & Lymphoma Society's Therapy Acceleration Program and receives a strategic investment of 3 million USD. Read more.
AegirBio announces the outcome of the exercise of warrants TO2. Read more.
Cessatech has decided on an option program for employees, the CEO and the board. Read more.
IRLAB has reported top-line results from the phase IIb study with mesdopetam (IRL790) in Parkinson's disease. Read more.
Eurocine Vaccines has decided to develop an mRNA-based vaccine candidate against chlamydia. Read more.
Scandinavian ChemoTech has updated on study of pancreatic cancer patients in Ukraine treated with TSE. Read more.
Analyst Group has published an analysis article about Coegin Pharma. Read more.
This morning's price development
Winner: Pharmacolog 25,3%, Xintela 11,1%, QuiaPEG 10,8%, Herantis 10,6%, Lipigon 9,5%
Förlorare: IRLAB Therapeutics -59,6%, Cline Scientific -15,6%, Idogen -13,4%, Learning 2 Sleep -11,6%, PolarCool -9,7%
Index: OMXS30% 2224 0,51%, Healthcare 0,02%
More from BioStock
» VILDA – new network for female leaders in life science
» Peptonic Medical's CEO on expansion plans
» Evaxion receives approval for Phase IIb study from FDA
» Drug development part V – The success of orphan drugs
» Dicot's CEO on preparations for clinic and IPO